Burrows Scott L sold SYRE
October 1, 2026 · Form 4 insider transaction
Burrows Scott L sold 229 shares of Spyre Therapeutics, Inc. at $93.57 per share, a transaction worth $21.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.; The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.54 to $93.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.; Includes 33,738 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. The RSUs vest on September 1, 2027, subject to the Reporting Person's continued employment with the Issuer.